Implementation of model-based dose adjustment of tobramycin in adult patients with cystic fibrosis

HIGHLIGHTS

• who: Jérémy Reverchon and colleagues from the Nord, Service Pharmacie, France have published the research: Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW 6 of 11 Abbreviations: Cmax, maximal concentration; Cmaxmod , concentration estimated 30 min after the end of a 30 min infusion; Cmin, trough concentration. Values are given as mean ± standard deviation unless otherwise stated. of 10/08/2022
• what: The authors aim at reporting the experience with tobramycin MIPD in adult patients with CF. Once . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.